Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer
18 Years
N/A
Both
Colorectal Cancer
Trial Information
Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer
Prospective project in collecting and assessing clinical outcomes data related to molecular
profiling of tumors based on cancer primary or metastatic tissue or tissue from peripheral
blood samples. As part of the project will be collected patient reported outcomes (PROs) for
assessing clinical outcomes in relation to clinical pathways, patient reported results, as
well as tumor profiling by molecular methods.
Inclusion Criteria:
- Diagnosis of colorectal cancer
- Informed consent to participate
- Age ≥18
Exclusion Criteria:
-
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Cancer-specific survival
Outcome Time Frame:
5-years
Safety Issue:
No
Principal Investigator
Kjetil Søreide, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Helse Stavanger HF
Authority:
Norway: Regional Ethics Commitee
Study ID:
29034/2012
NCT ID:
NCT01762813
Start Date:
August 2012
Completion Date:
December 2022
Related Keywords:
- Colorectal Cancer
- Colon cancer
- rectal cancer
- liver metastasis
- survival
- biomarker
- molecular profile
- Colorectal Neoplasms
Name | Location |
|---|
